Cerenome, Inc. (CNSY)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
CNSY price, last 12 months
Key stats
- Previous close
- $1.87
- Open
- $1.92
- Day range
- $1.92 – $2.08
- 52-week range
- $1.86 – $4.16
- Volume
- 204.2K
- Avg volume (20 days)
- 89.3K
- Market cap
- $15.1M
Performance
Technicals and fundamentals
About Cerenome, Inc.
Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $15.1M